Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
NCT02303964Phase 3Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- Nov 2014
- Primary completion
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
A Phase 3 trial of Fresh Frozen Plasma in hemorrhagic shock, sponsored by Virginia Commonwealth University. Planned start Nov 2014; status: withdrawn.
02
Drugs
Fresh Frozen Plasma
03
Conditions
hemorrhagic shock
Beyond the preview
Go deeper on NCT02303964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303964.